GEN and GSK Related Headlines

Go Back

GEN and GSK Related Press Releases

Go Back

May 19, 2014 02:21PM GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs Rituximab in Combination with Chemotherapy for the Treatment of Relapsed or

GEN and GSK Related SEC Filings

Go Back